BioReference Laboratories Announces Its Inclusion in the New NASDAQ Global Select Market

On July 3, NASDAQ-listed companies were reclassified under threelisting tiers -- NASDAQ Global Select Market, NASDAQ Global Market,and NASDAQ Capital Market. NASDAQ also plans to launch indexes basedon these new tiers.

"BioReference is proud to have met the standards required to belisted on the highest of the new NASDAQ tiers - the Global SelectMarket," said Marc D. Grodman, MD, CEO. "NASDAQ has raised the bar interms of listing qualifications. BioReference has made tremendousprogress over the past decade and it is important to both ouremployees and our shareholders that the NASDAQ recognizes ourimpressive financial results by including us in the market with thehighest listing standards in the world."

NASDAQ announced the new three tier listing classification inFebruary 2006. All three market tiers will maintain rigorous listingand corporate governance standards. For additional information aboutthe NASDAQ Global Select Market, please go to:www.nasdaq.com/GlobalSelect.

NASDAQ is the largest U.S. electronic stock market. Withapproximately 3,200 companies, it lists more companies and, onaverage, trades more shares per day than any other U.S. market. It ishome to companies that are leaders across all areas of businessincluding technology, retail, communications, financial services,transportation, media and biotechnology. NASDAQ is the primary marketfor trading NASDAQ-listed stocks. For more information about NASDAQ,visit www.nasdaq.com or the NASDAQ Newsroom athttp://www.nasdaq.com/newsroom/.

About BioReference Laboratories, Inc.

The Company is the largest independent regional clinicallaboratory in the Northeast and has major market positions inphysician offices, nursing homes and correctional institutions. TheCompany is a full service clinical laboratory with specialtycapability, especially in the areas of genomics, oncology,correctional health, and complimentary medicine. PSIMedica, a businessunit of the Company, is a clinical knowledge management (CKM)organization offering an array of information solutions for reducinghealthcare costs and improving quality performance that are based on aflexible, scalable software analytical engine that utilizes allavailable source information, including claims data, enrollment data,prescription data and laboratory data. The Company provides acomprehensive connectivity solution to physicians as well as otherlaboratories, which includes laboratory reporting and ordering, aswell as laboratory to physician communications and cumulativereporting, through CareEvolve, its web-based healthcare portal.

Statements included in this release that are not historical innature, are intended to be, and are hereby identified as"forward-looking statements". Statements looking forward in time areincluded in this release pursuant to the "safe harbor" provisions ofthe Private Securities Litigation Reform Act of 1995. Such statementsinvolve known and unknown risks and uncertainties that may cause theCompany's actual results in future periods to be materially differentfrom any future performance suggested herein.